IP Library Granted Patent US 8,962,864
Granted Patent B2
US 8,962,864 · App. 13/767,581 · Granted Feb 24, 2015

Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds

Inventor: Miroslav Rapta (San Carlos, CA)
Assignee: Theravance Biopharma R&D IP, LLC
C07D405/12C07D207/20C07D309/12C07D407/12C07D405/14C07D207/277C07D317/34C07D319/06C07D249/10C07D207/263
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,864
App. No.
13/767,581
Granted
Feb 24, 2015
Kind
B2
Abstract

The invention provides processes for preparing intermediates useful for preparing compounds of the formula: or a tautomer or salt thereof, where R 1 -R 5 , a, b, X and P 2 , are as defined in the specification.

Claims (17)

1. A process for preparing a compound of formula I:

or a salt thereof, where a is 0 or 1; R 4 is selected from halo, —CH 3 , —CF 3 , and —CN; b is 0 or an integer from 1 to 3; and each R 5 is independently selected from halo, —OH, —CH 3 , —OCH 3 , and —CF 3 ; the process comprising the step of reslurrying a compound of formula (1):

in an ether solvent to form a compound of formula I or a salt thereof.

2. The process of claim 1 , where the ether solvent is 2-methyltetrahydrofuran.

3. The process of claim 2 , where the ether solvent further comprises cyclopentyl methyl ether.

4. The process of claim 1 , where the compound of formula (1) is prepared by the acidic deprotection of a compound of formula (2):

where P 1 is an amino protecting group.

5. The process of claim 4 , where acidic deprotection is conducted with 3M HCl.

6. The process of claim 4 , where P 1 is selected from acetyl, adamantyl-oxycarbonyl, t-amyloxycarbonyl, benzothiophene sulfone-2-methoxycarbonyl, benzoyl, benzyl, benzyloxycarbonyl, 2-(p-biphenylyl)propyl-2-oxycarbonyl, t-butoxycarbonyl, 2-(t-butylsulfonyl)-2-propenyloxycarbonyl, 3,4-dimethoxybenzyl, 2,2-dimethyl-3,5-dimethyloxybenzyloxycarbonyl, dithiasuccinoyl, formyl, 9-fluorenylmethoxycarbonyl, 2-furanmethyloxycarbonyl, p-methoxybenzyl, p-methoxybenzyl carbonyl, 1-methylcyclobutyloxycarbonyl, o-nitrophenylsulfenyl, 2-phenylpropyl-2-oxycarbonyl, 2-(p-phenylazophenyl)propyl-2-oxycarbonyl, silyl ethers, tosyl, trifluoroacetyl, β-trimethylsilylethyloxycarbonyl, triphenylmethyl, and trityl.

7. The process of claim 6 , where P 1 is t-butoxycarbonyl.

8. A process for preparing a compound of formula IIa:

or a salt thereof, where a is 0 or 1; R 4 is selected from halo, —CH 3 , —CF 3 , and —CN; b is 0 or an integer from 1 to 3; and each R 5 is independently selected from halo, —OH, —CH 3 , —OCH 3 , and —CF 3 ; the process comprising the steps of (a) activation of the carboxyl group of a compound of formula I:

and (b) reacting the resulting product with a reducing agent to form a compound of formula IIa or a salt thereof.

9. The process of claim 8 , where step (a) is conducted with isobutyl chloroformate in the presence of a tertiary amine base.

10. The process of claim 9 , where the tertiary amine base is N-methylmorpholine.

11. The process of claim 8 , where the reducing agent is sodium tetrahydroborate.

12. The process of claim 1 , where the ether solvent is diisopropyl ether.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2026
From: THERAVANCE BIOPHARMA R&D IP, LLC
To: EONHF, INC.
Reel/Frame 075494/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033125/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: RAPTA, MIROSLAV
To: THERAVANCE, INC.
Reel/Frame 029816/0095 →
Continuity (2)
Provisional Application 61599020 · Feb 15, 2012
Related Publication 20130211098A1 · Aug 15, 2013